CHARACTERIZATION OF GLUTATHIONE CONJUGATES OF CHLORAMBUCIL BY FAST ATOM BOMBARDMENT AND THERMOSPRAY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY

被引:51
作者
DULIK, DM
COLVIN, OM
FENSELAU, C
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL & MOLEC SCI,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,CTR ONCOL,BALTIMORE,MD 21205
来源
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY | 1990年 / 19卷 / 04期
关键词
D O I
10.1002/bms.1200190408
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Chlorambucil (p‐(di‐2‐chloroethyl)amino‐γ‐phenylbutyric acid) is a bifunctional alkylating agent which exhibits acquired drug resistance upon repeated dosing in humans. This compound reacts with glutathione both nonenzymatically and enzymatically in the presence of immobilized microsomal glutathione‐S‐transferases to produce several glutathione conjugates. These conjugates result from displacement of one or both chlorines by the nucleophilic cysteine sulfhydryl moiety of glutathione. The mono‐ and diglutathionyl conjugates of chlorambucil were purified by reversed‐phase high‐performance liquid chromatography and characterized by positive ion fast atom bombardment mass spectrometry. In addition, the mono‐ and dihydroxy hydrolysis products of chlorambucil were characterized by positive ion thermospray liquid chromatography/mass spectrometry (LC/MS). The glutathione conjugates of chlorambucil did not produce molecular ion species in thermospray LC/MS mode, but gave characteristic ions at m/z 147 corresponding to fragmentation of the glutathione moiety. The formation of glutathione conjugates of this class of alkylating agents may play a role in the development of acquired drug resistance. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码:248 / 252
页数:5
相关论文
共 9 条
  • [1] PROTOCOL FOR LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY OF GLUTATHIONE CONJUGATES USING POSTCOLUMN SOLVENT MODIFICATION
    BEAN, MF
    PALLANTEMORELL, SL
    DULIK, DM
    FENSELAU, C
    [J]. ANALYTICAL CHEMISTRY, 1990, 62 (02) : 121 - 124
  • [2] CONNORS TA, 1984, HDB EXPT PHARM, V72, P403
  • [3] DULIK DM, 1987, DRUG METAB DISPOS, V15, P195
  • [4] CHARACTERIZATION OF MELPHALAN-GLUTATHIONE ADDUCTS WHOSE FORMATION IS CATALYZED BY GLUTATHIONE TRANSFERASES
    DULIK, DM
    FENSELAU, C
    HILTON, J
    [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (19) : 3405 - 3409
  • [5] ENHANCED MELPHALAN CYTOTOXICITY IN HUMAN OVARIAN-CANCER INVITRO AND IN TUMOR-BEARING NUDE-MICE BY BUTHIONINE SULFOXIMINE DEPLETION OF GLUTATHIONE
    OZOLS, RF
    LOUIE, KG
    PLOWMAN, J
    BEHRENS, BC
    FINE, RL
    DYKES, D
    HAMILTON, TC
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (01) : 147 - 153
  • [6] PALLANTE SL, 1986, DRUG METAB DISPOS, V14, P313
  • [7] ANALYSIS OF GLUTATHIONE CONJUGATES AND RELATED-COMPOUNDS BY THERMOSPRAY MASS-SPECTROMETRY
    PARKER, CE
    DEWIT, JSM
    SMITH, RW
    GOPINATHAN, MB
    HERNANDEZ, O
    TOMER, KB
    VESTAL, CH
    SANDERS, JM
    BEND, JR
    [J]. BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1988, 15 (11): : 623 - 634
  • [8] DECHLORINATION OF L-PHENYLALANINE MUSTARD BY SENSITIVE AND RESISTANT TUMOR-CELLS AND ITS RELATIONSHIP TO INTRACELLULAR GLUTATHIONE CONTENT
    SUZUKAKE, K
    VISTICA, BP
    VISTICA, DT
    [J]. BIOCHEMICAL PHARMACOLOGY, 1983, 32 (01) : 165 - 167
  • [9] WANG AL, 1985, CANCER TREAT REP, V69, P677